ENCOROL CR 500TABLET

Product Description

ENCOROL CR 500 Tablet
Composition: Sodium Valproate (333 mg) + Valproic Acid (145 mg)
Controlled Release | Antiepileptic | CNS Drug

ENCOROL CR 500 Tablet is a reliable and clinically proven antiepileptic formulation, combining Sodium Valproate and Valproic Acid to provide enhanced seizure control. Designed for sustained release, it ensures consistent therapeutic levels, minimizing dosing frequency and enhancing patient compliance.

Key Benefits:

• Effective management of generalized and partial seizures

• Dual-action composition enhances anticonvulsant efficacy

• Ideal for long-term neurological care

• Controlled-release formulation for improved bioavailability